Achieve Life Sciences, Inc. (ACHV)

Latest News

View All News

March 24, 2026 7:00 AM EDT

Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates View Press Release

Mar 17, 2026 8:30 am EDT

Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026

Mar 4, 2026 8:00 am EST

Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study

Jan 30, 2026 4:05 pm EST

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

View All News

Latest Presentation

Achieve Corporate Presentation January 2026 View Presentation

View All Presentations

Recent Event

Mar 24, 2026 8:30 am EDT Fourth Quarter 2025 Earnings Conference Call View Event

View All Events

Latest Financial Results

FY 2025

Fiscal Year Ended Dec 31, 2025

Earnings Release

Earnings Webcast

10-K XBRL Zip

View All Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2025

View 10-K

Company Overview

Achieve Life Sciences is a specialty pharmaceutical company committed to addressing the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline.

View Management Team View Board of Directors

IR Contacts

Headquarters

Achieve Life Sciences, Inc.
22722 29th Dr. SE
Suite 100
Bothell, WA 98021
United States
T: 425-686-1500

Investor Relations

Nicole Jones
T: 425-686-1510
ir@achievelifesciences.com